Moreover, and of clinical and therapeutic relevance, the effects of SEMA3F can be blocked directly through its coreceptors, thus preventing invasion and keeping DCIS lesions in the preinvasive state. The gene discussed is SEMA3F; the disease is ductal breast carcinoma in situ.